BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29254168)

  • 21. Polyamine flux analysis by determination of heavy isotope incorporation from 13C, 15N-enriched amino acids into polyamines by LC-MS/MS.
    Cerrada-Gimenez M; Häkkinen MR; Vepsäläinen J; Auriola S; Alhonen L; Keinänen TA
    Amino Acids; 2012 Feb; 42(2-3):451-60. PubMed ID: 21818565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct urinary metabolic profile of human colorectal cancer.
    Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
    J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells.
    Tolstikov V; Nikolayev A; Dong S; Zhao G; Kuo MS
    PLoS One; 2014; 9(12):e114019. PubMed ID: 25486521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ornithine is a key mediator in hyperphosphatemia-mediated human umbilical vein endothelial cell apoptosis: Insights gained from metabolomics.
    Zhou R; Kang X; Tang B; Mohan C; Wu T; Peng A; Liu JY
    Life Sci; 2016 Feb; 146():73-80. PubMed ID: 26773858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D
    Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UHPLC-MS-based metabolomics analysis on mice bearing neoplasm (H22) for hispidulin.
    Li F; Li X; Miao Y; Shan C; Yuan F; Ma C; Wang Q; Chen J; Chen Y
    J Pharm Biomed Anal; 2016 Jun; 125():310-8. PubMed ID: 27077962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
    Roy C; Tremblay PY; Bienvenu JF; Ayotte P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Profiling with Gas Chromatography-Mass Spectrometry and Capillary Electrophoresis-Mass Spectrometry Reveals the Carbon-Nitrogen Status of Tobacco Leaves Across Different Planting Areas.
    Zhao J; Zhao Y; Hu C; Zhao C; Zhang J; Li L; Zeng J; Peng X; Lu X; Xu G
    J Proteome Res; 2016 Feb; 15(2):468-76. PubMed ID: 26784525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Metabolomic Analysis of Head and Neck Cancer Cells Using High Performance Ion Chromatography Coupled with a Q Exactive HF Mass Spectrometer.
    Hu S; Wang J; Ji EH; Christison T; Lopez L; Huang Y
    Anal Chem; 2015 Jun; 87(12):6371-9. PubMed ID: 25973679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative metabolomics profiling of engineered Saccharomyces cerevisiae lead to a strategy that improving β-carotene production by acetate supplementation.
    Bu X; Sun L; Shang F; Yan G
    PLoS One; 2017; 12(11):e0188385. PubMed ID: 29161329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats.
    Bando K; Kunimatsu T; Sakai J; Kimura J; Funabashi H; Seki T; Bamba T; Fukusaki E
    J Appl Toxicol; 2011 Aug; 31(6):524-35. PubMed ID: 21154879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.
    Lee J; Lee I; Han B; Park JO; Jang J; Park C; Kang WK
    J Natl Cancer Inst; 2011 Apr; 103(8):674-88. PubMed ID: 21398618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of GC-MS based metabolomics analysis with mouse xenograft models reveals a panel of dysregulated circulating metabolites and potential therapeutic targets for colorectal cancer.
    Ni J; Chen Y; Li N; Sun D; Ju H; Chen Z
    Transl Cancer Res; 2021 Apr; 10(4):1813-1825. PubMed ID: 35116504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary Metabolic Pathway-Targeted Metabolomics.
    Vizcaino MI; Crawford JM
    Methods Mol Biol; 2016; 1401():175-95. PubMed ID: 26831709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement uncertainty of isotopologue fractions in fluxomics determined via mass spectrometry.
    Guerrasio R; Haberhauer-Troyer C; Steiger M; Sauer M; Mattanovich D; Koellensperger G; Hann S
    Anal Bioanal Chem; 2013 Jun; 405(15):5133-46. PubMed ID: 23559335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global serum metabolomics profiling of colorectal cancer.
    Hashim NAA; Ab-Rahim S; Suddin LS; Saman MSA; Mazlan M
    Mol Clin Oncol; 2019 Jul; 11(1):3-14. PubMed ID: 31289671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
    Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
    Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel integrated method for large-scale detection, identification, and quantification of widely targeted metabolites: application in the study of rice metabolomics.
    Chen W; Gong L; Guo Z; Wang W; Zhang H; Liu X; Yu S; Xiong L; Luo J
    Mol Plant; 2013 Nov; 6(6):1769-80. PubMed ID: 23702596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
    J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.